Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 22nd May 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 16, 2017
Previous Article Next Article

Optimization of pegylated iron oxide nanoplatforms for antibody coupling and bio-targeting

Author affiliations

Abstract

PEGylation has been established as a valuable strategy to minimize nanoparticle clearance by the reticulo-endothelial system due to hydrophilicity and steric repulsion of PEG chains. In this study we functionalized superparamagnetic iron oxide nanoparticle surface with two PEG differing in their length (n = 23 and 44) and terminal functionality, COOH and CH3. By varying the ratio of the two different PEG, we optimized the molecular architecture of the nanoplatform to obtain maximum stability and low toxicity under physiological conditions. The best nanoplatform was evaluated as MRI contrast for mouse brain vascularization imaging at 7 T. The carboxylic acid functions of the nanoplatform were used to covalently bind an antibody, Ab. This antibody, labeled with a fluorophore, targets the ETA receptor, a G-protein-coupled receptor involved in the endothelin axis and overexpressed in various solid tumours, including ovarian, prostate, colon, breast, bladder and lung cancers. In vitro studies, performed by flow cytometry and magnetic quantification, showed the targeting efficiency of the Ab-nanoplatforms. Clearly, an imaging tracer for cancer diagnosis from a bimodal contrast agent (fluorescence and MRI) was thus obtained.

Graphical abstract: Optimization of pegylated iron oxide nanoplatforms for antibody coupling and bio-targeting

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 Nov 2016, accepted on 22 Mar 2017 and first published on 22 Mar 2017


Article type: Paper
DOI: 10.1039/C6TB03080G
J. Mater. Chem. B, 2017,5, 2896-2907

  •   Request permissions

    Optimization of pegylated iron oxide nanoplatforms for antibody coupling and bio-targeting

    S. Richard, M. Boucher, A. Saric, A. Herbet, Y. Lalatonne, P. X. Petit, S. Mériaux, D. Boquet and L. Motte, J. Mater. Chem. B, 2017, 5, 2896
    DOI: 10.1039/C6TB03080G

Search articles by author

Spotlight

Advertisements